Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

If we needed a reason to drop a few pounds, Covid

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36563
(Total Views: 320)
Posted On: 08/04/2020 11:05:49 AM
Posted By: docj
If we needed a reason to drop a few pounds, Covid may be it. Maybe Generex can add weight loss clinics into the mix. Fits in nicely with all the diabetes work too.

So, Obesity Is a Risk for Poor COVID-19 Outcomes – Now What?
July 31, 2020
Ted Kyle, RPh, MBA


If we understand how the disease of obesity compounds COVID-19 severity, how do we put that knowledge to work?


Since the early days of the COVID-19 pandemic, we’ve seen a steady flow of data to suggest that obesity is a risk factor for severe symptoms with COVID-19. Not that obesity increases the risk for infection-but rather, when a person becomes infected with the new coronavirus, the risk of severe symptoms is much higher.

At first, the CDC listed only severe obesity – marked by a BMI >40 – as a risk factor. Later, though, the agency revised its guidance to include any degree of obesity, at a BMI ≥30.

The single most important risk factor is still age. But after age, obesity ranks high on the list of health issues that put a person at risk for severe illness if they develop COVID-19

The physiology behind the risk

Early on, some obesity experts speculated that one reason obesity might increase the risks with COVID-19 might have something to do with respiration. Hypoventilation syndrome can be an issue for people with obesity. Back then, experts were looking at COVID-19 primarily as a pulmonary problem.

However, as the understanding of COVID-19 grew, so did the appreciation that life-threatening complications have much to do with a systemic cascade of inflammation – sometimes referred to as a cytokine storm. It’s this overwhelming inflammation that causes severe damage to lungs and other vital organs.

Likewise, experts in the physiology of obesity have long known that much of the harm of obesity comes from the inflammation that an excess of adipose tissue can promote. This is especially true of visceral fat and ectopic fat. Fatty liver disease is very much an inflammatory condition. ACE2 receptors are plentiful in adipose tissue. Those receptors also serve as a means for the virus to trigger inflammation.

So, researchers suspect that the inflammation that comes with obesity, along with an abundance of ACE2 receptors in adipose tissue, most likely account for the added risk for complications with COVID-19 for individuals with obesity.

So What?

The question, then, is what are we supposed to do with this knowledge? One answer is that the knowledge of how obesity and COVID-19 interact gives researchers a clue for finding better ways to treat patients when these conditions overlap.

In addition, though, this insight can be helpful to the patients at risk. Not because they can easily lose weight and reduce their risk. That’s far more easily said than done. However, patients can act to keep themselves in good health and take extra care to avoid exposing themselves to the coronavirus. This is all about good self-care and following public health guidance. Maintaining social distance, staying home as much as possible, hand washing, and using a face mask are all important measures to take. These are measures that are good for all, but they pay extra health dividends to people living with obesity.





(1)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us